MedTrace Logo

Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain

NCT01512160 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2013-06-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the overall pain relief of a single dose of PF-04531083 against placebo following third molar extraction.

Conditions

  • Post-surgical Dental Pain

Interventions

DRUG

PF-04531083

2000 mg oral solution

OTHER

Placebo

Placebo tablets for Ibuprofen

DRUG

PF-04531083

1000 mg oral solution

OTHER

Placebo

Placebo tablets for Ibuprofen

DRUG

Ibuprofen

2 x 200 mg tablets

OTHER

Placebo

Placebo solution for PF-04531083

OTHER

Placebo

Placebo solution for PF-04531083

OTHER

Placebo

Placebo tablets for Ibuprofen

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-03-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01512160 on ClinicalTrials.gov